Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Soleno Therapeutics (SLNO) Preferred Dividend Payments (2016)

Soleno Therapeutics (SLNO) has disclosed Preferred Dividend Payments for 1 consecutive years, with $172.0 as the latest value for Q4 2016.

  • Quarterly Preferred Dividend Payments changed N/A to $172.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2016, changed N/A year-over-year, with the annual reading at $3.7 million for FY2016, N/A changed from the prior year.
  • Preferred Dividend Payments for Q4 2016 was $172.0 at Soleno Therapeutics, down from $3.7 million in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $3.7 million in Q3 2016, with the low at $172.0 in Q4 2016.